Events
Articles
- August 09, 2019War for Domain. What Should Company Do if Domain is Lost (in Russian)
- August 07, 2019Processing Employee’s Personal Data Before and After Employment (in Russian)
- August 05, 2019Subsidiary Liability. How to Determine Limitation Period After Three Law Amendments (in Russian)
- August 02, 2019Unlawful Actions of Creditor. Protecting Interests of Debtor (in Russian)
Recent Deals
Representing Japanese pharmaceutical company Santen in a dispute on debt recovery with a Russian distributor of medicines
Advising major international pharmaceuticals company Glenmark on several compliance issues, advertising law and activities aimed at promoting medical products on the Internet
Advising Japanese electronics company Sharp in a dispute with the Federal Tax Service (FTS) on the issue related to preliminary classification of a product and supplemental tax assessment
Legal support of the fund established by inheritors of the famous Tove Jansson in monitoring online and offline infringements and protecting their copyrights to Moomin characters in Russia
Lidings Expertise in Representing Pharmaceuticals and Healthcare Companies in Patent Disputes in Russia and CIS
The Russian pharmaceutical industry has recently become the field for serious patent-related battles between large foreign producers of original drugs and Russian manufacturers of generics. The originators are dissatisfied with the increasing attempts by generic drug producers to take over the markets even for those drugs that are effectively protected by patents.
Highlights of the Legal Brunch on Employment Law
Lidings runs traditional Legal Brunch, a client-oriented event organized in the form of an open dialogue between the firm’s experts and guests. This time on the issues of Employment Law...
Legal Digest: Patent Disputes in Life Sciences (EAEU, CIS, Eastern Europe)
Heaving vast expertise in providing legal protection to large Russian and international pharmaceuticals and healthcare companies, Lidings has put together a Legal Digest highlighting the most notable patents disputes in Life Sciences
